Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Scientific Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient age \>= 18 years
Documented permanent AF (for at least three months)
Scheduled for an open chest cardiac surgery for the primary indication of mitral valve repair or replacement
Has been informed of the nature of the study, agrees to its provisions, and provided written informed consent, which was approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site
You may not be if
Cerebral vascular accident (CVA, stroke) or transient ischemic attack (TIA) within the previous 6 months
Myocardial infarction within the previous 6 weeks
Documented history of pulmonary vein stenosis
Previous ablation attempt for AF
Previous thoracic procedures
Left atrial size \> 7.0 cm
Left ventricular ejection fraction \< 30%
Presence of left atrial or left atrial appendage thrombi
Esophageal fistula or other stricture, untreated esophagitis, varices, dysphagia or odynophagia contraindicating transesophageal echocardiography
Known allergy or contraindication to warfarin therapy
Known allergy or contraindication to antiarrhythmic (Classes IA, IC, III) therapy
Other comorbidity with reduced life expectancy of less than 1 year or protocol noncompliance that would limit follow-up
Geographically remote or unable to return for follow-up examinations
Pregnant or planning to become pregnant during the study
Enrolled in any concurrent study, without Guidant written approval, that may confound the results of the study
Clareo Health | Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
